At the end of the treatment phase, researchers measured changes in knee pain, function, and body weight
Support for a healthy liver*
Frequently Asked Questions Semaglutide and Tirzepatide are prescription GLP-1/GIP medications that help reduce appetite, curb cravings, and improve metabolic control, making weight loss easier to achieve and more sustainable under physician supervision
Pregnant women exposed to Wegovy and healthcare providers are encouraged to contact Novo Nordisk at 18007276500
Subcutaneous GLP-1 injections like semaglutide are safe and effective for weight loss, but bruising at injection sites affects up to 30% of patients during their first month
researchers to launch clinical trial Women in the study who were obese and taking GLP-1 weight loss medications were 30% less likely to develop breast cancer than other women